1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Crestchem Ltd

Crestchem Ltd

BBSE:CRSTCHM
154.00
INR
-3.00
(-1.91%)
11.02EPS
11.70P/E
387.00MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.39
0.32
0.44
0.2
0.17
0.09
20.35
25.02
26.48
55.43
70.61
83.4
98.55
112.79
Basic EPS, GAAP
-0.09
2.04
0.29
-0.54
-0.65
-0.57
1.48
1.91
1.89
2.31
7.15
9.09
9.05
11.02
Free Cash Flow per Basic Share
-0.95
0.17
-1
-0.22
-2.44
-0.07
1.11
0.15
2.73
7.37
1.16
5.18
11,973.86
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.25
536.63
- -
Book Value per Share
1.36
3.05
3.33
2.79
2.15
1.58
3.06
4.97
6.87
9.18
16.33
24.92
32.95
- -
Tangible Book Value per Share
1.36
3.05
3.33
2.79
2.15
1.58
3.06
4.97
6.87
9.18
16.33
24.92
32.95
- -
Basic Weighted Avg Shares
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Sales/Revenue/Turnover
4
1
1
1
1
- -
61
75
79
166
212
250
296
338
Operating Margin (%)
-5.85
-203.33
-45.84
-337.11
-481.75
-639.53
9
8.46
9.08
4.85
12.87
13.07
10.52
11.52
Depreciation Expense
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
691
1
Net Income, GAAP
- -
6
1
-2
-2
-2
4
6
6
7
21
27
27
33
Effective Tax Rate (%)
- -
10.47
27.53
- -
- -
- -
22.08
14.73
27.39
26.09
27.98
25.44
27.78
28.23
Profit Margin (%)
-6.21
644.75
64.82
-272.17
-373.09
-603.84
7.27
7.65
7.14
4.17
10.13
10.9
9.18
9.77
Working Capital
-1
9
5
7
4
2
7
12
-1
-8
1
13
-6
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
4
9
10
8
6
5
9
15
21
28
49
75
99
- -
Return on Invested Capital (%)
- -
-13.57
0.94
- -
- -
- -
49.38
34.07
22.86
23.13
50.61
38.87
22.91
- -
Return on Capital (%)
- -
60.03
7.4
- -
- -
- -
52.87
38.43
26.03
27.72
56.21
44.68
31.3
- -
Return on Common Equity (%)
-6.17
92.53
8.94
-17.61
-26.13
-30.33
63.73
47.63
31.94
28.82
56.09
44.06
31.26
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
337
233
387

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
57
- -
Cash, Cash Equivalents & STI
- -
4
- -
Accounts Receivable, Net
- -
36
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
63
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.52%
46.96%
32.56%
Free Cash Flow
23,236.58%
46,653.62%
231,054.9%
Net Income, GAAP
-35.7%
51.42%
-0.48%
Sales/Revenue/Turnover
2,171.77%
35.75%
18.17%
Total Cash Common Dividend
- -
- -
215,431.79%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
52
78
48
72
250
2026
50
72
72
102
296
2027
93
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.99
3.32
1.74
2.03
9.09
2026
1.16
1.82
2.39
3.67
9.05
2027
3.14
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.25
2026
- -
- -
- -
- -
536.63
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Dipak Narendraprasad Patel
Full Time Employees
5
Sector
Health technology
Industry
Pharmaceuticals: other
Address
303 B, Central Business Space Ahmedabad GU India 380013
IPO Date
Oct 27, 1993
Website
crestchemlimited.in
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Crestchem Limited manufactures, markets, and exports nutraceutical ingredients and nutrition-chemical products in India and internationally. The company produces medium chain triglycerides including caprylic/capric triglycerides in oil form and powders at 50% and 70% concentrations; lactose-free products such as spray-dried lactose-free skimmed milk powder and complete balanced nutrition formulations for pediatric and adult use; and oils and fats in water-soluble powder form comprising high oleic sunflower oil powder, palm oil powder, coconut oil powder, aromatic oil powder on dairy base, and dairy cream powder. Crestchem Limited undertakes developmental work on specialty products tailored to customer needs in the nutritional chemical sector. Incorporated in 1991 and listed on the BSE, the company maintains its registered office and factory at Sr. No. 550/1, Sub Plot No. 12, Village Indrad, Taluka Kadi, District Mehsana, Gujarat, with corporate office in Ahmedabad. In recent developments, Crestchem Limited appointed Nirmit Dipak Patel as Executive Director effective October 1, 2023; Jignesh A. Shah as Additional Director effective December 29, 2023 and Priyankaben M. Patel as Additional Director effective July 4, 2024, both proposed for regularization as Independent Directors up to September 30, 2029; approved continuation of Chairman and Managing Director Dipak N. Patel beyond age 70 and increased his remuneration to Rs 4-5 lakh monthly effective January 1, 2024; and in 2025 appointed Nitin S. Shah as Company Secretary, Compliance Officer, and CFO effective August 1 following resignations including that of prior CFO Khyati Vyas, amid board changes such as retirements of Rajesh I. Mody and Manojkumar Babubhai Patel in July 2024.